BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 11481417)

  • 1. Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines.
    Wolter F; Akoglu B; Clausnitzer A; Stein J
    J Nutr; 2001 Aug; 131(8):2197-203. PubMed ID: 11481417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines.
    Joe AK; Liu H; Suzui M; Vural ME; Xiao D; Weinstein IB
    Clin Cancer Res; 2002 Mar; 8(3):893-903. PubMed ID: 11895924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines.
    Wolter F; Clausnitzer A; Akoglu B; Stein J
    J Nutr; 2002 Feb; 132(2):298-302. PubMed ID: 11823594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.
    Ahmad N; Adhami VM; Afaq F; Feyes DK; Mukhtar H
    Clin Cancer Res; 2001 May; 7(5):1466-73. PubMed ID: 11350919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
    Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
    J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G1/S‑phase cell cycle arrest and apoptosis through caspase/cyclin‑CDK pathways.
    Liu B; Zhou Z; Zhou W; Liu J; Zhang Q; Xia J; Liu J; Chen N; Li M; Zhu R
    Mol Med Rep; 2014 Oct; 10(4):1697-702. PubMed ID: 25050564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of G1 and G2/M cell cycle arrests by the dietary compound 3,3'-diindolylmethane in HT-29 human colon cancer cells.
    Choi HJ; Lim DY; Park JH
    BMC Gastroenterol; 2009 May; 9():39. PubMed ID: 19480695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells.
    Delmas D; Passilly-Degrace P; Jannin B; Cherkaoui Malki M; Latruffe N
    Int J Mol Med; 2002 Aug; 10(2):193-9. PubMed ID: 12119558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
    Yu B; Lane ME; Pestell RG; Albanese C; Wadler S
    Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1.
    Scaglione-Sewell BA; Bissonnette M; Skarosi S; Abraham C; Brasitus TA
    Endocrinology; 2000 Nov; 141(11):3931-9. PubMed ID: 11089522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells.
    Bhatia N; Agarwal C; Agarwal R
    Nutr Cancer; 2001; 39(2):292-9. PubMed ID: 11759294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monensin-mediated growth inhibition of SNU-C1 colon cancer cells via cell cycle arrest and apoptosis.
    Park WH; Kim ES; Jung CW; Kim BK; Lee YY
    Int J Oncol; 2003 Feb; 22(2):377-82. PubMed ID: 12527937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC; Lin-Shiau SY; Chen CF; Lin JK
    J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention.
    Wang L; Liu D; Ahmed T; Chung FL; Conaway C; Chiao JW
    Int J Oncol; 2004 Jan; 24(1):187-92. PubMed ID: 14654956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol 3-O-D-glucuronide and resveratrol 4'-O-D-glucuronide inhibit colon cancer cell growth: evidence for a role of A3 adenosine receptors, cyclin D1 depletion, and G1 cell cycle arrest.
    Polycarpou E; Meira LB; Carrington S; Tyrrell E; Modjtahedi H; Carew MA
    Mol Nutr Food Res; 2013 Oct; 57(10):1708-17. PubMed ID: 23650147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis.
    Park WH; Kim ES; Kim BK; Lee YY
    Int J Oncol; 2003 Jul; 23(1):197-204. PubMed ID: 12792794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells.
    Parekh P; Motiwale L; Naik N; Rao KV
    Exp Toxicol Pathol; 2011 Jan; 63(1-2):167-73. PubMed ID: 20133117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G2/M cell cycle arrest and induction of apoptosis by a stilbenoid, 3,4,5-trimethoxy-4'-bromo-cis-stilbene, in human lung cancer cells.
    Lee EJ; Min HY; Joo Park H; Chung HJ; Kim S; Nam Han Y; Lee SK
    Life Sci; 2004 Oct; 75(23):2829-39. PubMed ID: 15464834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
    Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH
    Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.